Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.

Damm O, Ultsch B, Horn J, Mikolajczyk RT, Greiner W, Wichmann O.

BMC Public Health. 2015 Jun 5;15:533. doi: 10.1186/s12889-015-1861-8. Review.

2.

Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada.

Rivière M, Tretiak R, Levinton C, Fitzsimon C, Leclerc C.

Can J Infect Dis. 1997 Sep;8(5):257-64.

3.

Burden of chickenpox on families: A study in Quebec.

De Wals P, Blackburn M, Guay M, Bravo G, Blanchette D, Douville-Fradet M.

Can J Infect Dis. 2001 Jan;12(1):27-32.

4.

Vaccination to prevent varicella and shingles.

Breuer J.

J Clin Pathol. 2001 Oct;54(10):743-7.

5.

Varicella vaccination--a critical review of the evidence.

Skull SA, Wang EE.

Arch Dis Child. 2001 Aug;85(2):83-90. Review. No abstract available.

6.

Immunisation against chickenpox.

Ross LF, Lantos JD.

BMJ. 1995 Jan 7;310(6971):2-3. No abstract available.

7.

Impact and costs of varicella prevention in a university hospital.

Weber DJ, Rutala WA, Parham C.

Am J Public Health. 1988 Jan;78(1):19-23.

8.

The use of varicella vaccine in Britain.

Kangro HO, Heath RB.

Br Med J (Clin Res Ed). 1988 Apr 23;296(6630):1194-5. No abstract available.

9.
Items per page

Supplemental Content

Write to the Help Desk